KMS Medisurgi Board Meeting on Nov 14 to Review H1 FY27 Results

KMS Medisurgi Ltd has announced that its Board of Directors will convene on November 14, 2026, to consider and approve the Un-Audited Financial Results for the half-year ended September 30, 2026, along with the limited review report. The meeting will also address any other business items. Concurrently, the company has implemented a trading window closure for designated persons and their relatives from October 1, 2026, which will remain in effect for 48 hours post the declaration of the financial results.